[关键词]
[摘要]
中心性浆液性脉络膜视网膜病变(central serous chorioretinopathy， CSC)是一种与多种因素有关的疾病，其具体发病机制尚未明确。除了阈下微脉冲激光治疗、低剂量光动力疗法(photodynamic therapy，PDT)等治疗方法外，基于病因学治疗的药物如血管内皮生长因子(vascular endothelial growth factor， VEGF)拮抗剂、甲氨蝶呤、依普利酮(eplerenon)、幽门螺杆菌治疗药物等已经被用于CSC的实验性治疗。本文旨在回顾有关CSC治疗方面的文献，以期为CSC的临床治疗提供参考。
[Key word]
[Abstract]
Central serous chorioretinopathy(CSC)is a disease that associated with multifactors. The specific pathogenesis is not yet clear. Except for subthreshold micropulse laser treatment and reduced dose photodynamic therapy(PDT), drugs based on etiology of CSC, such as anti-vascular endothelial growth factor(VEGF), methotrexate, eplerenone, anti-helicobacter pylori, have been applied to experimental treatment. The purpose of this article is to review the literature in the treatment of CSC, and to provide reference for clinical treatment of CSC.
[中图分类号]
[基金项目]
